Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
aorta | immunohistochemistry shows PAF-AH expression in the intima and in the media of the aorta | Homo sapiens | - |
artery | detected by immunohistochemistry in the media of mammary arteries | Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.0000008 | - |
transacetylase activity of mammary artery | Homo sapiens |
0.0000033 | - |
transacetylase activity in aorta | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
1-alkyl-2-acetyl-sn-glycero-3-phosphocholine + lyso-phosphatidylcholine | - |
Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
PAF-AH | enzyme inactivates PAF bioactivity and possesses both acetylhydrolase and transacetylase activities | Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | lyso- platelet-activating factor accumulation and an increase in platelet-activating factor bioactivity is observed in the aorta of some patients. In atherogenic aortas, an imbalance between PAF-AH and transacetylase activity, as well as lyso-platelet-activating factor accumulation, may lead to unregulated platelet-activating factor formation and to progression of atherosclerosis | Homo sapiens |